SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: JFD who wrote (5786)3/3/1998 6:20:00 PM
From: Colby  Respond to of 23519
 
I do think this stock is not going to do a whole lot in the SR. However, lets assume analysts are somewhat correct when they call for $ .75 this year and $2.91 next year. If this is the case, I wouldn't expect a whole lot of price jump until the end of the year as we start looking foward to '99. At that point, if we put a 20 x multiple on '99 earnings we are looking @ a $58 stock. That is over a 5 bagger in 2 years. I will certainly take it or anything close. I realize this might be realistically optimistic, but its only to make a point.
If this thing goes to thirty in '99, its still a great buy.

If you have a bad stomach, don't eat spicy foods,
Colby



To: JFD who wrote (5786)3/3/1998 8:31:00 PM
From: MisterED  Respond to of 23519
 
It is interesting that the number of institutions holding
Vivus as of 2-27-98, according to the Market Guide web site,
is as shown below (as of 2-13-98 in brackets):

No.of instituttions 182 (179)
3 months purchases - millions 9.31 (8.72)
3 months sales - millions 7.41 (7.44)
3 mo. net purchases - millions 1.90 (1.28)
% owned by institutions 65.98% (64.04%)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News